# Lyrica CR

NDC: 58151-246
Generic name: PREGABALIN
Labeler / Manufacturer: Viatris Specialty LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20241126

FDA application: NDA209501

## Active ingredients

- PREGABALIN: 165 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58151-246"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58151-246
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f280bbd8-2af2-444a-bd96-e409337ca6dd